c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK2

Petr Vanhara1, Vítezslav Bryja, Viktor Horváth

  • 1Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.

Insights

The transcription factor c-Jun induces cyclin A expression and cyclin-dependent kinase 2 (CDK2) activity, leading to programmed cell death in leukemia cells. Inhibiting CDK2 reduces this apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • c-Jun is a key component of activating protein-1 (AP-1), a transcription factor regulating cell proliferation, differentiation, and apoptosis.
  • Understanding c-Jun's role in cell cycle regulation and apoptosis is crucial for cancer research, particularly in leukemic cells.

Purpose of the Study:

  • To investigate the functional interactions between c-Jun and G1/S transition regulators in serum-deprived v-myb-transformed chicken monoblasts (BM2).
  • To elucidate the role of c-Jun in inducing programmed cell death in these leukemic cells.

Main Methods:

  • Utilized v-myb-transformed chicken monoblasts (BM2) under serum-deprived conditions.
  • Analyzed the effect of c-Jun expression on cyclin A and cyclin-dependent kinase 2 (CDK2) activity.
  • Investigated the impact of specific CDK2 inhibition on apoptosis frequency.

Main Results:

  • c-Jun expression induced cyclin A, leading to increased cyclin A-associated CDK2 activity.
  • This upregulation resulted in massive programmed cell death in BM2cJUN cells.
  • Specific inhibition of CDK2 significantly suppressed the frequency of apoptosis in BM2cJUN cells.

Conclusions:

  • Upregulation of cyclin A expression and CDK2 activity by c-Jun is a critical link between the transcription factor, cell cycle machinery, and programmed cell death.
  • This pathway represents a potential therapeutic target in leukemic cells.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...